Skip to main content
. 2019 Mar 11;9(4):e01254. doi: 10.1002/brb3.1254

Figure 1.

Figure 1

Glibenclamide attenuates brain edema and improves neurological outcomes in mice after intracerebral hemorrhage (ICH) by maintaining the integrity of the blood–brain barrier (BBB). (a) Compared to vehicle, glibenclamide significantly reduced the brain water content in the affected hemisphere after ICH. (b) Glibenclamide decreased the extravasation of Evans Blue in the brain after ICH. (c) Glibenclamide preserved the ICH‐induced degradation of the tight junction protein zona occludens‐1 (ZO‐1). (d) Glibenclamide improved neurological outcomes 3 and 7 days following ICH. (n = 4 in sham group, n = 6 in ICH group, *p < 0.05, **p < 0.01)